66th Annual Meeting of the Japanese Society of Neurology

Yi-chun Kuan^1,2,3, Cheng-chang Yang¹, Ko-yen Huang⁴, Jung-lung Hsu⁵ (1.Department of Neurology, Shuang-Ho Hospital, Taipei Medical University, New Taipei City, Taiwan, 2.Taipei Neuroscience Institute, Taipei Medical University, New Taipei City, Taiwan, 3.Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, 4.Department of Physical Medicine and Rehabilitation, Shuang-Ho Hospital, Taipei Medical University, Taiwan, 5.Department of Neurology, New Taipei Municipal Tu Cheng Hospital, New Taipei City, Taiwan)

Yuichi Higashiyama^1,3,4, Ramon Landin-romero^2,4, Keisuke Morihara¹, Shoko Ota⁵, Nobuko Kawakami⁵, Takeshi Ito¹, Hiroshi Doi¹, Kyoko Suzuki⁵, Kirrie Ballard^2,4, Olivier Piguet^3,4, Fumiaki Tanaka¹ (1.Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Japan, 2.School of Health Sciences, Facility of Medicine and Health, The University of Sydney, Australia, 3.School of Psychology, Faculty of Science, The University of Sydney, Australia, 4.Brain & Mind Centre, The University of Sydney, Australia, 5.Department of Behavioral Neurology and Cognitive Neuroscience, Tohoku University Graduate School of Medicine, Japan)

Ayako Sakoda^1,2, Tomohiro Imamura^2,3, Atsushi Ohno⁴, Guzailiayi Maimaitijiang², Ken-ichiro Yamashita^1,2, Yuki Yanagihara^1,2, Akira Yokote¹, Keiko Haro^1,2, Yasutaka Iwanaga^1,2, Yuri Nakamura^1,2,3, Keisuke Mizutani⁵, Mikiko Nakano⁵, Mari Shinoda⁵, Kaoru Yagita⁵, Nobutaka Sakae⁶, Naokazu Sasagasako⁶, Motohiro Yukitake⁷, Masakazu Hashimoto⁴, Noriko Isobe⁵, Jun-ichi Kira^1,2,3 (1.Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital, International University of Health and Welfare, Japan, 2.Translational Neuroscience Research Center, Graduate School of Medicine, International University of Health and Welfare, Japan, 3.Department of Pharmaceutical Sciences, School of Pharmacy at Fukuoka, International University of Health and Welfare, Japan, 4.Platform Technology Research Unit, Drug Research Division, Sumitomo Pharma Co., Ltd., Japan, 5.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 6.Department of Neurology, National Hospital Organization, Omuta Hospital, Japan, 7.Department of Neurology, Kouhoukai Takagi Hospital, International University of Health and Welfare, Japan)

Ataru Igarashi¹, Mayaka Tani², Mie Azuma², Takuro Utsumi², Carolyn Bodnar³, Se Ryeong Jang⁴, Hidetoshi Shibahara⁵, Sachie Inoue⁵, Oliver Burn⁶, Kate Molloy⁶, David Truman⁶, Gaku Kamanaka², Yuta Kamada⁴, Yukinori Sakata², Kiyoyuki Tomita² (1.Graduate School of Pharmaceutical Sciences, The University of Tokyo, Japan, 2.Eisai Co.,Ltd., Japan, 3.Eisai Europe Ltd., UK, 4.Eisai Inc., USA, 5.Crecon Medical Assessment, Japan, 6.Source Health Economics, UK)

Akinori Futamura^1,2, Ryuta Kinno¹, Yuki Hanazuka³, Ryuta Ochi⁴, Akira Midorikawa⁵, Shigeru Kitazawa⁶, Kenjiro Ono^2,7, Mitsuru Kawamura² (1.Division of Neurology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Kanagawa, Japan, 2.Division of Neurology, Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan, 3.Department of Management Information, Hokkai Gakuen University, Hokkaido, Japan, 4.Department of Psychology, Graduate School of Letters, Chuo University, Tokyo, Japan, 5.Department of Psychology, Faculty of Letters, Chuo University, Tokyo, Japan, 6.Dynamic Brain Network Laboratory, Graduate School of Frontier Biosciences, Osaka University, Osaka, Japan, 7.Department of Neurology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan)